The American College of Radiology® (ACR®) Center for Research and Innovation is managing a new study (EAQ201) to help identify COVID-19-related economic factors that may keep women from taking part in the landmark Tomosynthesis Mammographic Imaging Screening Trial (TMIST).
Specifically, this ECOG-ACRIN Cancer Research Group study’s primary objective is to compare the proportion of women of color (WOC) versus (vs) non-WOC to assess the COVID-19 related financial hardship and distress in those who decline TMIST participation.
Funded by the National Cancer Institute, the study’s secondary endpoints include documentation of an array of economic and lifestyle factors regarding their decision to not participate in TMIST as well as their breast cancer risk.
Current NCORP TMIST sites can go to www.ctsu.org and search EAQ201 to find all trial related materials.
For additional information please contact the Project Manager, Jessica Howell at firstname.lastname@example.org.